UnitedHealth’s Battle to Regain Investor Confidence

The past year has presented UnitedHealth with its most severe market challenges since the 2008 financial crisis. The healthcare behemoth, weighed down by regulatory probes, executive turnover, and withdrawn profit forecasts, is now attempting to engineer a turnaround through a sweeping independent review. As CEO Stephen Hemsley outlines specific reform measures, shareholders are left questioning whether these steps will be sufficient to bridge the deep operational and legal divides the company faces.

The stock’s performance starkly illustrates the necessity of the company’s current transparency drive. Having shed 43.15 percent of its value since the start of the year, UnitedHealth shares are on track for their worst annual performance in 17 years. This Read more...